Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • neoanderson
    Junior Member
    • Apr 2010
    • 6

    #1

    standard operating procedure 454 analysis

    Hello all,
    Im new to 454 data analysis. I have a 6mbp genome that has been sequenced at>10X. this is an emerging bacterial pathogen.
    what sort of post 454 data analysis should one do? does anyone have any standard operating procedures?
    As of now, I have a broad idea of what I would like to do. I have listed some of them below. I would appreciate any comments/suggestions.
    1)with the 400 or so contigs, I intend to align it with reference genomes(mauve? - will this help me in judging the quality of assembly?).
    2)carry out a rast server based annotation
    3)extract nucleotide and protein sequences from the gbk output of rast. (what is the best way to do it such that protein sequences are obtained as fastA with the product name as header rather than contig number?)
    4)carry out multiway blast searches against related genomes
    5)look out for presence of plasmids in the contigs by searching for regions of high coverage?
    6)look for regions of atypical nucleotide composition ?

    I would really appreciate your thoughts on this post.
    Thanks very much !
  • Loris
    Junior Member
    • Dec 2009
    • 6

    #2
    I think I can plug xBASE services here.

    I suggest you use my-xBASE to align your data to a reference, also try de-novo assembly. Then use the annotation service to generate a preliminary annotation.

    xBASE main page - my-xBASE and annotation services linked in the right column.

    for (5), I plot a graph of contig length vs. reads/length. Plasmid contigs stick out from the vast majority of large contigs at a non-integral multiple of the read-density.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...